A new AI framework that can help doctors build better tools

Artificial intelligence can help predict a patient's risk for conditions such as sepsis, heart disease and cancer. But many of these tools fall short in real-life clinical practice because they are difficult for doctors to ...

FDA expands use of kidney cancer drug belzutifan

Belzutifan, a first-in-class drug that arose from scientific discoveries at UT Southwestern Medical Center, has been approved by the Food and Drug Administration to treat some patients with earlier-stage kidney cancers in ...

page 3 from 30